Optimizing Outcomes in Relapsed and Refractory Multiple Myeloma: Personalized Approaches and Adverse Event Management
Year: 2025
Type: article
Source: American Journal of Hematology
DOI: 10.1002/ajh.27646
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Janssen Pharmaceuticals
OpenAlex ID: W4410078505
